Publication of List of Manufacturers Revoked from Licensing for the Manufacture of Therapeutic Goods – 4 May 2022

Overview

The Therapeutic Goods Act 1989 was enacted to provide a framework for the regulation of therapeutic goods in Australia, ensuring that these products are safe, of high quality, and effective. The Act was introduced to address the need for a cohesive regulatory system that would oversee the manufacture, importation, supply, and advertising of therapeutic goods, thereby protecting public health. This legislation was enacted by the Parliament of Australia and its primary policy objective is to safeguard the health and safety of the Australian population by regulating therapeutic goods, including medicines, medical devices, and blood and blood components. On 4 May 2022, Katherine Clark, as a delegate of the Secretary of the Department of Health, published details regarding the revocation of a Licence to Manufacture Therapeutic Goods held by Metro South Hospital and Health Service T/A Queensland Eye Bank. This revocation was executed under Section 41 of the Therapeutic Goods Act 1989, specifically Section 41(1)(d), and was carried out at the request of the manufacturer. This action reflects the ongoing commitment of the Therapeutic Goods Administration to maintain stringent standards in the manufacturing and supply of therapeutic goods across Australia.

Scope and Application

The Therapeutic Goods Act 1989 applies to any person or entity involved in the supply or marketing of therapeutic goods within Australia. This encompasses a broad range of industries including, but not limited to, pharmaceuticals, medical devices, blood, tissues, and complementary medicines. The Act governs the manufacturing, importation, advertising, and labelling of therapeutic goods, ensuring that they meet the required safety, quality, and efficacy standards. The geographic reach of the Act is national, as it applies across the Commonwealth of Australia, including all states and territories. The Act does, however, permit exclusions and exemptions for certain goods under specific circumstances, such as for research purposes or for goods intended for personal use. The Therapeutic Goods Administration, an agency within the Department of Health, has the authority to issue licences and to revoke them if the terms of the licence are not met or if it is in the public interest to do so. The scope of the Act can be extended or restricted through subordinate instruments, which provide further detail on the implementation and enforcement of the Act’s provisions.

Key Provisions

The Therapeutic Goods Act 1989 contains provisions for the regulation of therapeutic goods in Australia. Specifically, section 41(1)(d) allows the Secretary to revoke a licence to manufacture therapeutic goods. This section is pertinent when the Secretary, acting on the request of the manufacturer, revokes the licence of a specific entity engaged in the manufacture of therapeutic goods. In this instance, the licence held by Metro South Hospital and Health Service T/A Queensland Eye Bank, with the licence number MI-06092006-LI-001493-11, has been revoked. This revocation occurred at the request of the manufacturer, as stated in the notice published by Katherine Clark, Delegate of the Secretary of the Department of Health, Therapeutic Goods Administration. The obligations and requirements imposed by the Therapeutic Goods Act 1989 on entities like the Metro South Hospital and Health Service T/A Queensland Eye Bank include adherence to stringent manufacturing standards and compliance with the specific regulations governing the production of therapeutic goods. These obligations are designed to ensure that the therapeutic goods produced meet the necessary safety, efficacy, and quality standards. Entities with a licence to manufacture therapeutic goods must maintain records, submit reports, and comply with any additional conditions set by the Secretary to ensure ongoing compliance with the Act. Under the Therapeutic Goods Act 1989, breaches of the Act's provisions can lead to various consequences. While specific offences, penalties, or civil/criminal consequences are not detailed in the notice, it is known that the Act provides for enforcement actions against entities that fail to comply with its requirements. These actions may include fines, suspension or revocation of licences, and other penalties as prescribed by the Act. The seriousness of the breach typically dictates the severity of the penalty, with maximum penalties potentially applying in cases of significant non-compliance or deliberate misconduct. The revocation of the licence itself serves as a strong indicator of the regulatory body's response to non-compliance.